PT  - JOURNAL ARTICLE
AU  - Jiawen Deng
TI  - The effect of calcium and vitamin D on bone mineral density in patients taking glucocorticoid therapies: Protocol for a systematic review and network meta-analysis
AID  - 10.1101/2020.05.24.20112177
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.24.20112177
4099  - http://medrxiv.org/content/early/2020/05/25/2020.05.24.20112177.short
4100  - http://medrxiv.org/content/early/2020/05/25/2020.05.24.20112177.full
AB  - Glucocorticoid (GC) administration is an effective therapy commonly used in the treatment of autoimmune and inflammatory diseases. However, the use of GC can give rise to serious complications. The main detrimental side effect of GC therapy is significant bone loss, resulting in glucocorticoid-induced osteoporosis (GIOP).We performed a systematic review and network meta-analysis (NMA) to evaluate whether the use of calcium supplementation, with or without vitamin D, vitamin D metabolites and vitamin D analogues is capable of increasing bone mineral density (BMD) at the lumbar spine, femoral neck, and hip in adult patients undergoing glucocorticoid therapies compared to no treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This preprint describes a meta-analysis protocol and thus do not require ethics approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data available for this study.